Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region

Background & Objectives: Biological disease-modifying antirheumatic drugs (bDMARDs) for the treatment of rheumatoid arthritis (RA) are not always accessible to all patients in accordance with international guidelines, partly owing to their high direct costs against a background of restricted hea...

Full description

Saved in:
Bibliographic Details
Main Authors: Zoltán Kaló (Author), Zoltán Vokó (Author), Andrew Östör (Author), Emma Clifton-Brown (Author), Radu Vasilescu (Author), Alysia Battersby (Author), Edward Gibson (Author)
Format: Book
Published: Taylor & Francis Group, 2017-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available